http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1eb428d0771fdeae9c618c3f84965e7b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | C. Hahn Hahn |
| name | William C Hahn William. C Hahn William C. Hahn |
| given-name | William C. William. C William William C |
| organization-name | Broad Institute of Harvard and the Massachusetts Institute of Technology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; From the Department of Medical Oncology, Dana–Farber Cancer Institute, Boston, and the Broad Institute of Harvard and MIT, Cambridge — both in Massachusetts. Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts Center for Cancer Genome Discovery, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; the Authors' Affiliations: 1Broad Institute of Harvard and MIT, Cambridge;; 2Department of Medical Oncology, Dana-Farber Cancer Institute; Divisions of 1Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School;; 3Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts; and Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115 USA; Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, MA 02142 USA. Authors' Affiliations: 1Departments of Medical Oncology and 2Cancer Biology; 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute;4Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; 5Broad Institute of Harvard and MIT, Cambridge, Massachusetts; and 6Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina; Authors' Affiliations: 1Departments of Medical Oncology and 2Cancer Biology; 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute;4Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; 5Broad Institute of Harvard and MIT, Cambridge, Massachusetts; and 6Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina; Authors' Affiliations: 1Departments of Medical Oncology and 2Cancer Biology; 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute;4Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; 5Broad Institute of Harvard and MIT, Cambridge, Massachusetts; and 6Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina; Authors' Affiliations: 1Departments of Medical Oncology and 2Cancer Biology; 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute;4Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; 5Broad Institute of Harvard and MIT, Cambridge, Massachusetts; and 6Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina Division of Pediatric Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA 02115. 2Dana-Farber Cancer Institute, Boston, Massachusetts.; 3Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; 4Brigham and Women's Hospital, Boston, Massachusetts. 2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; 4Broad Institute of MIT and Harvard, Cambridge, Massachusetts. The Whitehead Institute for Biomedical Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142; Department of Adult Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115; Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912; and Terry Fox Laboratory, British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, British Columbia, V5Z 1L3 Canada 1Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; 3Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; 4Harvard Medical School, Boston, Massachusetts. Authors' Affiliations: Departments of 1Biostatistics and Computational Biology, and 2Medical Oncology; 3Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; 4Department of Biostatistics, Harvard School of Public Health; 5Department of Pathology; 6Translational Medicine Division, Brigham and Women's Hospital, Boston; 7Broad Institute of Harvard and MIT, Cambridge, Massachusetts; 8Sidney Kimmel Cancer Center; 9Department of Pathology, Johns Hopkins University, Baltimore, Maryland; 10Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 11Hospital del Mar Research Institute-IMIM, Barcelona; and 12Hospital Parc Tauli, Sabadell, Spain; Authors' Affiliations: Departments of 1Biostatistics and Computational Biology, and 2Medical Oncology; 3Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; 4Department of Biostatistics, Harvard School of Public Health; 5Department of Pathology; 6Translational Medicine Division, Brigham and Women's Hospital, Boston; 7Broad Institute of Harvard and MIT, Cambridge, Massachusetts; 8Sidney Kimmel Cancer Center; 9Department of Pathology, Johns Hopkins University, Baltimore, Maryland; 10Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 11Hospital del Mar Research Institute-IMIM, Barcelona; and 12Hospital Parc Tauli, Sabadell, Spain Authors' Affiliations: 1Center for Cancer Genome Discovery and 2Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Departments of 3Pathology and 4Medicine, Brigham and Women's Hospital, Boston; 5Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: 1Center for Cancer Genome Discovery and 2Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Departments of 3Pathology and 4Medicine, Brigham and Women's Hospital, Boston; 5Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: 1Center for Cancer Genome Discovery and 2Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Departments of 3Pathology and 4Medicine, Brigham and Women's Hospital, Boston; 5Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: 1Center for Cancer Genome Discovery and 2Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Departments of 3Pathology and 4Medicine, Brigham and Women's Hospital, Boston; 5Broad Institute of Harvard and MIT, Cambridge, Massachusetts Department of Medical Oncology,; Center for Cancer Genome Discovery,; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142; and; Departments of fMedicine and Broad Institute of Harvard and MIT, 7 Cambridge Center , Cambridge, Massachusetts 02142, USA ; Department of Medical, Dana-Farber Cancer Institute , 450 Brookline Avenue, Boston, Massachusetts 02215, USA ; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute , 450 Brookline Avenue, Boston, Massachusetts 02215, USA ; Departments of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, USA. G. Celine Han, Justin Hwang, Stephanie A.M. Wankowicz, Zhenwei Zhang, David Liu, Scott L. Carter, William C. Hahn, Mary-Ellen Taplin, and Eliezer M. Van Allen, Dana-Farber Cancer Institute; Glenn C. Gaviola, Varand Ghazikhanian, William C. Hahn, and Eliezer M. Van Allen, Brigham and Women’s Hospital; Glenn J. Bubley and Steven P. Balk, Beth Israel Deaconess Medical Center, Boston; G. Celine Han, Justin Hwang, Stephanie A.M. Wankowicz, David Liu, Carrie Cibulskis, Scott L. Carter, William C. Hahn, and... Department of Medical Oncology,; Center for Cancer Genome Discovery and; Broad Institute of Harvard and MIT, Cambridge, MA 02142;; Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts Departments of Medical Oncology and Biostatistical Science, Dana–Farber Cancer Institute, Boston, MA 02115; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115; Department of Medicine, Harvard Medical School, Boston, MA 02115; Broad Institute of Harvard and Massachusetts Institute of Technology, 320 Charles Street, Cambridge, MA 02139; Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720; and Terry Fox Laboratory, British Columbia Cancer Agency,... Authors' Affiliations: 1Department of Medical Oncology and 2Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston; 3Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Authors' Affiliations: 1Department of Medical Oncology and 2Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston; 3Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Authors' Affiliations: 1Department of Medical Oncology and 2Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston; 3Broad Institute of MIT and Harvard, Cambridge, Massachusetts 1Department of Medical Oncology, Dana-Farber Cancer Institute;; 3Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and; 4Broad Institute of Harvard and MIT, Cambridge, Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts Department of Medical Oncology, Dana–Farber Cancer Institute and Harvard Medical School, Boston, MA 02115;; Center for Cancer Genome Discovery, Dana–Farber Cancer Institute, Boston, MA 02115;; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142; and; Medicine, and 1Department of Medical Oncology, Dana-Farber Cancer Institute and Departments of Medicine, Brigham and Women's Hospital and; 2Department of Pathology, Harvard Medical School, Boston, Massachusetts;; 3Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts; and Department of Medicine and Institute for Molecular Medicine and Cell Research, University of Freiburg, 79106 Freiburg, Germany; Department of Medical Oncology, Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA 02115; and Gastroenterology Division, Abramson Cancer Center and Department of Genetics, University of Pennsylvania, Philadelphia, PA 19104 Authors' Affiliations: 1Department of Cancer Biology, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS/INSERM/Université de Strasbourg, Illkirch, France; and 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts Cancer Program, Cambridge, MA 02142; Dana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, MA 02215 From the Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. 1Center for Cancer Genome Discovery and Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; 3Broad Institute of Harvard and MIT, Cambridge, MA 02141, USA 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 5Broad Institute, Boston, Massachusetts.; 10Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts. Authors' Affiliations: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 2VIB Institute, Center of Human Genetics, KULeuven, Leuven, Belgium; and 3Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 2VIB Institute, Center of Human Genetics, KULeuven, Leuven, Belgium; and 3Broad Institute of Harvard and MIT, Cambridge, Massachusetts 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts. From the Dana-Farber Cancer Institute, Harvard Medical School, Boston; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA. 6The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; 7Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Departments of aMedical Oncology,; Center for Cancer Genome Discovery, and; Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142;; Medicine, Harvard Medical School, Boston, MA 02115 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts;; 2Department of Medicine, Brigham and Women’s Hospital, Harvard Medical, Boston, Massachusetts; and Dana-Farber Cancer Institute 1 Division of Cell Growth and Regulation , 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 3Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; 4Harvard Medical School, Boston, Massachusetts. Department of Adult Oncology, Dana-Farber Cancer Institute; Department of Medicine; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142 1Medical Oncology, Departments of; 4Medicine and; 6Medicine and; 7Pathology, Harvard Medical School, Boston, Massachusetts; and; 8Broad Institute of MIT and Harvard and 3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; 4Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Department of Medical Oncology, Dana–Farber Cancer Institute and Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115;; Cancer Genomics Project, Center for Medical Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; and Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts; Harvard Medical School Boston Massachusetts; Center for Cancer Genome Discovery Dana‐Farber Cancer Institute Boston Massachusetts; Broad Institute of Harvard and Massachusetts Institute of Technology Cambridge Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States; Broad Institute of Harvard and MIT, Cambridge, United States Cancer Program, Broad Institute, Cambridge, Massachusetts3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Boston, Massachusetts, USA; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Medical Oncology, and; Harvard Medical School, Boston, MA 02115; and; Broad Institute of Harvard and MIT, Cambridge, MA 02142 Department of Medical Oncology and Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115;; Cancer Program, The Broad Institute of Harvard and MIT, Cambridge, MA 02142; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142; Department of Adult Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115 1Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts.; 3Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Department of Adult Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women's Hospital; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Authors' Affiliations: 1Peter MacCallum Cancer Centre, East Melbourne; 2Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Melbourne; 3Sir Peter MacCallum Department of Oncology; 4Departments of Pathology, 5Biochemistry and Molecular Biology, and 6Medicine; 7Centre for Translational Pathology, University of Melbourne, Parkville, Victoria, Australia; 8Dana-Farber Cancer Institute, Boston; and 9The Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: 1Peter MacCallum Cancer Centre, East Melbourne; 2Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Melbourne; 3Sir Peter MacCallum Department of Oncology; 4Departments of Pathology, 5Biochemistry and Molecular Biology, and 6Medicine; 7Centre for Translational Pathology, University of Melbourne, Parkville, Victoria, Australia; 8Dana-Farber Cancer Institute, Boston; and 9The Broad Institute of Harvard and MIT, Cambridge, Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Woman's Hospital and Harvard Medical School, Boston, MA 02115; and; Broad Institute of Harvard and MIT, Cambridge, MA 02142 Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115 Department of Medical Oncology and Dana-Farber Cancer Institute (W.C.H.), Boston, Massachusetts 02115 4Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Massachusetts; and; 5Broad Institute, Cambridge, Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Authors' Affiliations: Departments of 1Medical Oncology and 2Cancer Biology, Dana-Farber Cancer Institute; 3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston; 4Broad Institute of Harvard and MIT, Cambridge; 5MGH Cancer Center, 6Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, Massachusetts; and 7Department of Surgery, Division of Biology and Biomedical Sciences, Washington University, St. Louis, Missouri; Authors' Affiliations: Departments of 1Medical Oncology and 2Cancer Biology, Dana-Farber Cancer Institute; 3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston; 4Broad Institute of Harvard and MIT, Cambridge; 5MGH Cancer Center, 6Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, Massachusetts; and 7Department of Surgery, Division of Biology and Biomedical Sciences, Washington University, St. Louis, Missouri Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts (J.N., S.X., V.L., Y.S., P.B., R.B., T.M.R., C.D.S., R.A.S., J.J.Z.); Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts (J.N., S.X., V.L., T.M.R., J.J.Z.); Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachu Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215;; Broad Institute of MIT and Harvard University, Cambridge, MA 02142; 1Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.; 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 7Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.; 8Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and; Broad Institute of MIT and Harvard, Cambridge, MA 1Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; 3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts.; 4Harvard Medical School, Boston, Massachusetts.; 9Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medical Oncology,; Center for Cancer Genome Discovery, and; Departments of bMedicine and; Broad Institute of Harvard and MIT, Cambridge, MA 02142; 1Department of Medical Oncology, Dana-Farber Cancer Institute; Departments of; 2Medicine and; 4Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. 1Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 3Harvard Medical School, Boston, Massachusetts.; 5Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;; Department of Medicine, Brigham & Women's Hospital, Boston, MA;; Department of Medicine, Harvard Medical School, Boston, MA;; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA;; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142;; Department of Medical Oncology and Center for Cancer Genome Discovery and; Harvard Medical School, Boston, MA 02115; Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; Harvard Medical School, Boston, Massachusetts 02115, USA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA Broad Institute of Harvard and Massachusetts Institute of Technology, 7 Cambridge Center, Cambridge, MA 02142, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142, USA.; Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA 02115, USA. 6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 1 Department of Biostatistics, Dana-Farber Cancer Institute, 2Department of Biostatistics, Harvard School of Public Health, 3Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA and 4Department of Statistics, Seoul National University, Seoul, Korea. 1Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.; 4Departments of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology and; Departments of Medicine and Genetics, Harvard Medical School, Boston, MA 02115;; Broad Institute of Harvard and MIT, Cambridge, MA 02142; and 3Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; 4Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology and 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School; 4Department of Pathology, Harvard Medical School; 5Department of Pathology, Brigham and Women's Hospital; 6Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; 7Broad Institute of M.I.T. and Harvard and 8Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology and 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School; 4Department of Pathology, Harvard Medical School; 5Department of Pathology, Brigham and Women's Hospital; 6Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; 7Broad Institute of M.I.T. and Harvard and 8Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology and 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School; 4Department of Pathology, Harvard Medical School; 5Department of Pathology, Brigham and Women's Hospital; 6Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; 7Broad Institute of M.I.T. and Harvard and 8Novartis Institutes for Biomedical Research, Cambridge, Massachusetts Department of Medical Oncology,; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA 02115;; Cancer Program and; Department of Medicine and 6Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts 5Medical Oncology and; 7Broad Institute of Harvard and MIT, Cambridge, Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115; Departments of Medicine and Pathology, Harvard Medical School, Boston, Massachusetts 02115; and Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02139 Whitehead Institute for Biomedical Research, Cambridge, MA 02142; Department of Adult Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115; Departments of Medicine and Pathology, Harvard Medical School, Boston, MA 02115; Genzyme, Inc., One Kendall Square, Cambridge, MA 02139; Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, MD 20892; and Department of Biology, Massachusetts Institute of... |
Incoming Links
Total number of triples: 388.